Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
David N. Westerdahl, MD, is a Staff physician for the Department of Orthopaedic Surgery at Cleveland Clinic Florida. Dr. Westerdahl completed his Doctor of Medicine Degree at Loma Linda University in 2000 after receiving a B. A. in Business Administration from Washington State University in 1996. Once completing his residency in Family Medicine at Florida Hospital in Orlando, he served a primary care sports medicine fellowship in the Department of Orthopaedic Surgery at Cleveland Clinic's main campus in Cleveland, Ohio.
With a background in primary care and sports medicine, Dr. Westerdahl manages a wide range of non-operative orthopaedic and sports medicine injuries. He is the team physician for the Florida Panthers hockey team, consulting physician for the USTA Development Center in Boca Raton, and serves as team physician for The Sagemont School in Weston, Florida. His specialty interests include sports injuries, medical orthopedics, exercise related medical disorders, performance testing, musculoskeletal ultrasound, nutritional supplements and wilderness medicine.
Dr. Westerdahl is a diplomate of the American Board of Family Practice with a Certificate of Added Qualification in Sports Medicine. His memberships in various medical organizations and societies include the American College of Sports Medicine, American Academy of Family Practice, the American Medical Society for Sports Medicine, Society of Tennis Medicine and Science, and the Florida Academy of Family Practice.
sports injuries, exercise related medical disorders, MSK ultrasound for diagnostic and therapeutic applications, fractures of the upper and lower extremities, arthritis, extra-corporeal shock wave,
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/28/2015, Dr. Westerdahl has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.